Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Not applicable Interventional Results available

PROMISE I Early Feasibility Trial of the LimFlow Stent Graft System

ClinicalTrials.gov ID: NCT03124875

Public ClinicalTrials.gov record NCT03124875. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 5:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Pilot Study to Investigate Safety, Effectiveness and Feasibility of LimFlow Stent Graft System for Creating an AV Fistula for the Treatment of Critical Limb Ischemia

Study identification

NCT ID
NCT03124875
Recruitment status
Completed
Study type
Interventional
Phase
Not applicable
Lead sponsor
LimFlow, Inc.
Industry
Enrollment
32 participants

Conditions and interventions

Interventions

  • LimFlow System Device

Device

Eligibility (public fields only)

Age range
21 Years to 95 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 4, 2017
Primary completion
Aug 7, 2019
Completion
Jan 4, 2021
Last update posted
May 20, 2024

2017 – 2021

United States locations

U.S. sites
7
U.S. states
7
U.S. cities
7
Facility City State ZIP Site status
Medstar Washington Hospital Center Washington D.C. District of Columbia 20010
Kaiser Permanente Honolulu Hawaii 96817
Metro Health, University of Michigan Wyoming Michigan 49519
New Mexico Heart Institute Albuquerque New Mexico 87102
Mount Sinai Health System New York New York 10029
University Hospitals Cleveland Medical Center Cleveland Ohio 44106
Palmetto Health Columbia South Carolina 29203

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03124875, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted May 20, 2024 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03124875 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →